{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:35:53Z","timestamp":1791387353126,"version":"4.3.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s12020-019-01962-5","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T09:55:32Z","timestamp":1559382932000},"page":"656-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hyperprolactinemia diagnosis in elderly men: a cohort of 28 patients over 65 years"],"prefix":"10.1007","volume":"65","author":[{"given":"Ilan","family":"Shimon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dania","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tsvetov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Robenshtok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Akirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Fraenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Eizenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Herzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Barzilay-Yoseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Livner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilana","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Manisterski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Ishay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Yoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,1]]},"reference":[{"key":"1962_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1530\/eje.0.1480325","volume":"148","author":"A Colao","year":"2003","unstructured":"A. Colao, A.D. Sarno, P. Cappabianca, F. Briganti, R. Pivonello, C.D. Somma, A. Faggiano, B. Biondi, G. Lombardi, Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur. J. Endocrinol. 148, 325\u2013331 (2003)","journal-title":"Eur. J. Endocrinol."},{"key":"1962_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillman","year":"2006","unstructured":"M.P. Gillman, M.E. Molitch, G. Lombardi, A. Colao, Advances in the treatment of prolactinomas. Endocr. Rev. 27, 485\u2013534 (2006)","journal-title":"Endocr. Rev."},{"key":"1962_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11102-005-5084-3","volume":"8","author":"A Ciccarelli","year":"2005","unstructured":"A. Ciccarelli, E. Guerra, M. De Rosa, F. Milone, S. Zarrilli, G. Lombardi, A. Colao, PRL secreting adenomas in male patients. Pituitary 8, 39\u201342 (2005)","journal-title":"Pituitary"},{"key":"1962_CR4","first-page":"316","volume":"41","author":"A Tirosh","year":"2016","unstructured":"A. Tirosh, I. Shimon, Current approach to treatments for prolactinomas. Minerva Endocrinol. 41, 316\u2013323 (2016)","journal-title":"Minerva Endocrinol."},{"key":"1962_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/EJE-09-0012","volume":"160","author":"E Delgrange","year":"2009","unstructured":"E. Delgrange, T. Daems, J. Verhelst, R. Abs, D. Maiter, Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients. Eur. J. Endocrinol. 160, 747\u2013752 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"1962_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1530\/eje.0.1380286","volume":"138","author":"M De Rosa","year":"1998","unstructured":"M. De Rosa, A. Colao, A. Di Sarno, D. Ferone, M.L. Landi, S. Zarrilli, L. Paesano, B. Merola, G. Lombardi, Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine. Eur. J. Endocrinol. 138, 286\u2013293 (1998)","journal-title":"Eur. J. Endocrinol."},{"key":"1962_CR7","first-page":"2102","volume":"82","author":"E Delgrange","year":"1997","unstructured":"E. Delgrange, J. Trouillas, D. Maiter, J. Donckier, J. Tourniaire, Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. J. Clin. Endocrinol. Metab. 82, 2102\u20132107 (1997)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1962_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12020-014-0259-1","volume":"47","author":"I Shimon","year":"2014","unstructured":"I. Shimon, M.D. Bronstein, J. Shapiro, G. Tsvetov, C. Benbassat, A. Barkan, Women with prolactinomas presented at the postmenopausal period. Endocrine 47, 889\u2013894 (2014)","journal-title":"Endocrine"},{"key":"1962_CR9","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/cen.13399","volume":"87","author":"S Santharam","year":"2017","unstructured":"S. Santharam, M. Tampourlou, W. Arlt, J. Ayuk, N. Gittoes, A. Toogood, R. Webster, N. Karavitaki, Prolactinomas diagnosed in the postmenopausal period: Clinical phenotype and outcomes. Clin. Endocrinol. 87, 508\u2013514 (2017)","journal-title":"Clin. Endocrinol."},{"key":"1962_CR10","first-page":"505","volume":"63","author":"M Impallomeni","year":"1987","unstructured":"M. Impallomeni, T. Yeo, A. Rudd, D. Carr, V. Aber, Investigation of anterior pituitary function in elderly in-patients over the age of 75. Q. J. Med. 63, 505\u2013515 (1987)","journal-title":"Q. J. Med."},{"key":"1962_CR11","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000022079","volume":"45","author":"E Delgrange","year":"1999","unstructured":"E. Delgrange, D. Maiter, J. Donckier, J. Tourniaire, Influence of age on the clinical presentation of prolactinomas in male patients. Gerontology 45, 160\u2013164 (1999)","journal-title":"Gerontology"},{"key":"1962_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/ageing\/afh108","volume":"33","author":"P Iglesias","year":"2004","unstructured":"P. Iglesias, L.P. Macho, J.J. D\u00edez, Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. Age Ageing 33, 410\u2013412 (2004)","journal-title":"Age Ageing"},{"key":"1962_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-33","volume":"4","author":"FR Maclean","year":"2010","unstructured":"F.R. Maclean, J.P. Hanley, Prolactinoma presenting as chronic anaemia with osteoporosis: a case report. J. Med. Case Rep. 4, 33 (2010)","journal-title":"J. Med. Case Rep."},{"key":"1962_CR14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1532-5415.2010.02922.x","volume":"58","author":"T Kitchen","year":"2010","unstructured":"T. Kitchen, R. Coles, A. Smith, P. Baglioni, O.E. Okosieme, Giant prolactinoma in an elderly man. J. Am. Geriatr. Soc. 58, 1402\u20131404 (2010)","journal-title":"J. Am. Geriatr. Soc."},{"key":"1962_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11102-010-0251-6","volume":"14","author":"I Shimon","year":"2011","unstructured":"I. Shimon, C. Benbassat, G. Tzvetov, S. Grozinsky-Glasberg, Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression. Pituitary 14, 11\u201315 (2011)","journal-title":"Pituitary"},{"key":"1962_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/cen.12375","volume":"80","author":"I Bancos","year":"2014","unstructured":"I. Bancos, M.R. Nannenga, J.M. Bostwick, M.H. Silber, D. Erickson, T.B. Nippoldt, Ipulse control disorders in patients with dopamine agonist-treated prolactinomas and nonfunctioning pituitary adenomas: a case\u2013control study. Clin. Endocrinol. 80, 863\u2013868 (2014)","journal-title":"Clin. Endocrinol."},{"key":"1962_CR17","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12020-016-1088-1","volume":"55","author":"SM De Sousa","year":"2017","unstructured":"S.M. De Sousa, I.M. Chapman, H. Falhammar, D.J. Torpy, Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine 55, 618\u2013624 (2017)","journal-title":"Endocrine"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-019-01962-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-019-01962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T23:34:06Z","timestamp":1590881646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-019-01962-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,1]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["1962"],"URL":"https:\/\/doi.org\/10.1007\/s12020-019-01962-5","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,1]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ilan Shimon, has received research grants, consulting, and lectureship fees from Novartis International AG, Medison Pharma, and Pfizer Inc. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee, and with the 1964 Helsinki declaration and its later amendments, or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}